| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 197.336 | 230.763 | 172.900 | 134.318 | 112.544 | 96.008 | 90.678 | 102.004 | 64.531 | 41.908 |
| Total Income - EUR | 207.094 | 237.638 | 183.069 | 137.946 | 115.129 | 97.592 | 93.895 | 104.376 | 66.243 | 42.315 |
| Total Expenses - EUR | 205.112 | 232.868 | 191.245 | 130.435 | 115.661 | 92.291 | 97.152 | 109.081 | 80.260 | 68.787 |
| Gross Profit/Loss - EUR | 1.981 | 4.770 | -8.176 | 7.512 | -532 | 5.301 | -3.257 | -4.705 | -14.017 | -26.472 |
| Net Profit/Loss - EUR | 1.981 | 4.770 | -9.920 | 6.129 | -1.682 | 4.351 | -4.196 | -5.748 | -14.017 | -26.472 |
| Employees | 3 | 3 | 3 | 3 | 3 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Biosens Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 94.095 | 111.387 | 100.240 | 97.484 | 77.272 | 67.918 | 71.380 | 77.264 | 70.641 | 45.138 |
| Inventories | 23.781 | 25.074 | 32.884 | 21.372 | 15.740 | 4.931 | 23.669 | 19.704 | 23.862 | 6.013 |
| Receivables | 63.706 | 50.058 | 37.360 | 71.564 | 46.875 | 57.776 | 44.648 | 54.168 | 44.774 | 30.698 |
| Cash | 6.609 | 36.255 | 29.996 | 4.548 | 14.657 | 5.210 | 3.063 | 3.391 | 2.005 | 8.427 |
| Shareholders Funds | -35.895 | -30.759 | -40.158 | -33.292 | -34.329 | -29.327 | -32.873 | -38.723 | -52.623 | -78.801 |
| Social Capital | 225 | 223 | 219 | 215 | 211 | 207 | 202 | 203 | 202 | 201 |
| Debts | 129.990 | 142.146 | 140.398 | 130.776 | 111.602 | 97.245 | 104.253 | 115.987 | 123.264 | 123.938 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4775 - 4775" | |||||||||
| CAEN Financial Year |
4775
|
|||||||||
Comments - Biosens Srl